L Camille Bedrosian

Director at Rhythm Pharmaceuticals Inc. (RYTM), 2025-06-23
at Crinetics Pharmaceuticals Inc. (CRNX), 2025-06-13
Chief Medical Officer at Amylyx Pharmaceuticals Inc. (AMLX), 2025-04-02
Evp And Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), 2023-03-04

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
AMLX	$3.47	12,425	$43,082.45	194,375	2025-03-31	Filing
AMLX	$5.54	5,421	$30,007.40	138,380	2024-12-02	Filing
AMLX	$3.20	11,442	$36,559.48	143,801	2024-09-30	Filing
RARE	$45.25	3,881	$175,615.25	46,720	2023-03-01	Filing
RARE	$66.62	2,821	$187,935.02	33,938	2022-03-01	Filing